PCM
Puissance Capital Management Portfolio holdings
AUM
$17.3M
This Quarter Return
+58.92%
1 Year Return
+149.36%
3 Year Return
+115.5%
5 Year Return
–
10 Year Return
–
AUM
$123M
AUM Growth
+$123M
(+40%)
Cap. Flow
-$4.62M
Cap. Flow
% of AUM
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$3.9M |
| 2 |
SPDR S&P Biotech ETF
XBI
|
$716K |
Sector Composition
| 1 | Healthcare | 54.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ekso Bionics
EKSO
$10.3M
| $51.5M | 41.92% |
20,534,898
| – | – |
|
|
VRAY
2
DELISTED
ViewRay, Inc.
VRAY
| $50.6M | 41.13% |
6,842,975
| – | – |
|
|
KDMN
3
DELISTED
Kadmon Holdings, Inc.
KDMN
| $7.97M | 6.49% |
3,020,596
-1,478,756
| -33% | -$3.9M |
|
|
TCON
4
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $6.3M | 5.13% |
4,601,768
| – | – |
|
|
BLPH
5
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $5.42M | 4.41% |
8,298,755
| – | – |
|
6
Corvus Pharmaceuticals
CRVS
$422M
| $1.15M | 0.93% |
284,869
| – | – |
|
|
7
SPDR S&P Biotech ETF
XBI
$5.25B
| – | – |
-9,986
| Closed | -$716K |
|